ESSA Pharma Inc. Files Q2 2025 10-Q Financials
| Field | Detail |
|---|---|
| Company | Essa Pharma Inc. |
| Form Type | 10-Q |
| Filed Date | May 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
ESSA Pharma's Q2 2025 10-Q is in. Financials updated.
AI Summary
ESSA Pharma Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the second quarter of fiscal year 2025. Key financial statement line items such as retained earnings, additional paid-in capital, and accumulated other comprehensive income are reported as of March 31, 2025, and compared to previous periods.
Why It Matters
This filing provides investors with an update on ESSA Pharma's financial health and performance for the most recent quarter, crucial for investment decisions.
Risk Assessment
Risk Level: low — This is a routine financial filing with no immediate red flags or significant new disclosures.
Key Numbers
- 20250331 — Reporting Period End Date (Indicates the end of the fiscal quarter for which financial data is reported.)
- 20250508 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- ESSA Pharma Inc. (company) — Filer of the 10-Q
- March 31, 2025 (date) — End of the reporting period
- 20250331 (date) — Conformed period of report
- 0001633932 (company) — Central Index Key for ESSA Pharma Inc.
FAQ
What is the primary purpose of this 10-Q filing?
The primary purpose is to provide a comprehensive update on ESSA Pharma Inc.'s financial performance and position for the quarterly period ending March 31, 2025.
What specific financial metrics are highlighted for March 31, 2025?
The filing highlights metrics such as retained earnings, additional paid-in capital, and accumulated other comprehensive income as of March 31, 2025.
What fiscal year and quarter does this 10-Q cover?
This 10-Q covers the second quarter of fiscal year 2025, ending on March 31, 2025.
When was this 10-Q filing submitted to the SEC?
This 10-Q filing was submitted to the SEC on May 8, 2025.
What is ESSA Pharma Inc.'s Standard Industrial Classification?
ESSA Pharma Inc.'s Standard Industrial Classification is Pharmaceutical Preparations [2834].
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 8, 2025 regarding ESSA Pharma Inc..